FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 151 filers reported holding FIVE PRIME THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.75 and the average weighting 0.3%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $137,000 | +260.5% | 3,615 | +61.0% | 0.00% | – |
| Q4 2020 | $38,000 | +280.0% | 2,245 | +13.3% | 0.00% | – |
| Q3 2020 | $10,000 | -16.7% | 1,981 | +1.5% | 0.00% | – |
| Q2 2020 | $12,000 | +140.0% | 1,951 | -15.5% | 0.00% | – |
| Q1 2020 | $5,000 | -75.0% | 2,308 | -48.7% | 0.00% | – |
| Q4 2019 | $20,000 | +185.7% | 4,501 | +129.5% | 0.00% | – |
| Q3 2019 | $7,000 | +75.0% | 1,961 | +180.1% | 0.00% | – |
| Q2 2019 | $4,000 | -69.2% | 700 | -26.3% | 0.00% | – |
| Q1 2019 | $13,000 | +85.7% | 950 | +30.3% | 0.00% | – |
| Q4 2018 | $7,000 | -69.6% | 729 | -56.8% | 0.00% | – |
| Q3 2018 | $23,000 | -32.4% | 1,688 | -21.6% | 0.00% | – |
| Q2 2018 | $34,000 | +6.2% | 2,152 | +15.1% | 0.00% | – |
| Q1 2018 | $32,000 | +39.1% | 1,870 | +74.9% | 0.00% | – |
| Q4 2017 | $23,000 | -82.6% | 1,069 | -66.8% | 0.00% | – |
| Q3 2017 | $132,000 | +428.0% | 3,223 | +282.3% | 0.00% | – |
| Q2 2017 | $25,000 | -91.7% | 843 | -89.9% | 0.00% | – |
| Q1 2017 | $302,000 | +1.0% | 8,330 | +39.5% | 0.00% | – |
| Q4 2016 | $299,000 | -59.0% | 5,973 | -57.0% | 0.00% | – |
| Q3 2016 | $730,000 | +1680.5% | 13,905 | +1290.5% | 0.00% | – |
| Q2 2016 | $41,000 | +173.3% | 1,000 | +3.7% | 0.00% | – |
| Q3 2015 | $15,000 | – | 964 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|